NEWHALL CHARLES W III

Average Profitability
10.53%
Insider Buys Quantity
2
Insider Buys Sum
$28.5M
Insider Sells Quantity
2
Insider Sells Sum
$166,145.00

Insider Activity of NEWHALL CHARLES W III

According to the SEC Form 4 filings, NEWHALL CHARLES W III, being in a position of

  1. director at Supernus Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2500 shares for $70,025,
    over all time since 2012-05-04, has bought 4400000 shares for $22M, and sold 2500 shares for $70,025.

The largest purchase of all time was on 2012-05-04 and amounted to 4400000 shares of Supernus Pharmaceuticals, Inc. for $22M.

The largest sale of all time was on 2007-06-05 and amounted to 6408 shares of Amicus Therapeutics, Inc. for $96,120.

Biography of NEWHALL CHARLES W III

No biography is available at this moment.

2023-11-16SaleSupernus Pharmaceuticals, Inc.
SUPN
director
2,500
0.0046%
$28.01$70,025+5.85%
2012-05-04PurchaseSupernus Pharmaceuticals, Inc.
SUPN
4.4M
21.9118%
$5.00$22M+29.48%
2012-03-07PurchaseAmicus Therapeutics, Inc.
FOLD
10 percent owner
1.14M
3.1412%
$5.70$6.5M-8.42%
2007-06-05SaleAmicus Therapeutics, Inc.
FOLD
10 percent owner
6,408
0.0969%
$15.00$96,120-17.97%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.